These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 17424796)

  • 1. [The role of steroids in the treatment of COPD].
    Reynard C
    Rev Med Suisse; 2007 Feb; 3(99):457-8, 460-1. PubMed ID: 17424796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacologic treatments for chronic obstructive pulmonary disease: a mixed-treatment comparison meta-analysis.
    Baker WL; Baker EL; Coleman CI
    Pharmacotherapy; 2009 Aug; 29(8):891-905. PubMed ID: 19637942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Inhaled corticosteroid/beta-2 agonist therapy in moderate COPD].
    Yıldırım N
    Tuberk Toraks; 2010; 58(2):192-201. PubMed ID: 20865575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimizing maintenance therapy for chronic obstructive pulmonary disease: strategies for improving patient-centered outcomes.
    Hanania NA
    Clin Ther; 2007 Oct; 29(10):2121-33. PubMed ID: 18042470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of bronchodilators in chronic obstructive pulmonary disease.
    Weder MM; Donohue JF
    Semin Respir Crit Care Med; 2005 Apr; 26(2):221-34. PubMed ID: 16088439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-acting bronchodilator therapy for the treatment of chronic obstructive pulmonary disease.
    Chen AM; Bollmeier SG; Finnegan PM
    Ann Pharmacother; 2008 Dec; 42(12):1832-42. PubMed ID: 18957624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhaled corticosteroids in chronic obstructive pulmonary disease: a review.
    Telenga ED; Kerstjens HA; Postma DS; Ten Hacken NH; van den Berge M
    Expert Opin Pharmacother; 2010 Feb; 11(3):405-21. PubMed ID: 20102305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes associated with tiotropium use in patients with chronic obstructive pulmonary disease.
    Lee TA; Wilke C; Joo M; Stroupe KT; Krishnan JA; Schumock GT; Pickard AS
    Arch Intern Med; 2009 Aug; 169(15):1403-10. PubMed ID: 19667304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quality of life measurements and bronchodilator responsiveness in prescribing nebulizer therapy in COPD.
    Brophy C; Kastelik J; Gardiner E; Greenstone M
    Chron Respir Dis; 2008; 5(1):13-8. PubMed ID: 18303097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Inhaled corticosteroids in patients with COPD: maintain current guidelines].
    Heijdra YF
    Ned Tijdschr Geneeskd; 2007 Oct; 151(40):2195-7. PubMed ID: 17969568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A stepwise approach to management of stable COPD with inhaled pharmacotherapy: a review.
    Restrepo RD
    Respir Care; 2009 Aug; 54(8):1058-81. PubMed ID: 19650947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interventions to reduce the frequency of exacerbations of chronic obstructive pulmonary disease.
    Black PN; McDonald CF
    Postgrad Med J; 2009 Mar; 85(1001):141-7. PubMed ID: 19351641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Drug therapies of COPD].
    Noseda A
    Rev Med Brux; 2003 Sep; 24(4):A354-7. PubMed ID: 14606301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of chronic obstructive pulmonary disease: moving beyond the asthma algorithm.
    Gordon E; Lazarus SC
    J Allergy Clin Immunol; 2009 Nov; 124(5):873-80; quiz 881-2. PubMed ID: 19895979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Practice guideline 'Medical treatment of COPD'].
    Dekhuijzen PN; Broeders ME; Tuut MK; Grol MH
    Ned Tijdschr Geneeskd; 2008 Jun; 152(26):1465-8. PubMed ID: 18666664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Steroid therapy in chronic obstructive pulmonary disease.
    OBrien A; Ward NS
    Med Health R I; 2002 Feb; 85(2):52-5. PubMed ID: 11881166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Tiotropium, a long-acting bronchodilating agent for the treatment of COPD].
    Schuurbiers OC; Schermer TR; Dekhuijzen PN; van Weel C
    Ned Tijdschr Geneeskd; 2006 Jun; 150(22):1227-32. PubMed ID: 16796173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New treatments for chronic obstructive pulmonary disease and viable formulation/device options for inhalation therapy.
    Onoue S; Misaka S; Kawabata Y; Yamada S
    Expert Opin Drug Deliv; 2009 Aug; 6(8):793-811. PubMed ID: 19558334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benefits and risks of adjunctive inhaled corticosteroids in chronic obstructive pulmonary disease: a meta-analysis.
    Sobieraj DM; White CM; Coleman CI
    Clin Ther; 2008 Aug; 30(8):1416-25. PubMed ID: 18803985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival among COPD patients using fluticasone/salmeterol in combination versus other inhaled steroids and bronchodilators alone.
    Mapel DW; Nelson LS; Lydick E; Soriano J; Yood MU; Davis KJ
    COPD; 2007 Jun; 4(2):127-34. PubMed ID: 17530506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.